Differential roles of Aβ processing in hypoxia-induced axonal damage

Neurobiology of Disease
Melissa G Christianson, Donald C Lo

Abstract

Axonopathy is a common and early phase in neurodegenerative and traumatic CNS diseases. Recent work suggests that amyloid β (Aβ) produced from amyloid precursor protein (APP) may be a critical downstream mediator of CNS axonopathy in CNS diseases, particularly those associated with hypoxia. We critically tested this hypothesis in an adult retinal explant system that preserves the three-dimensional organization of the retina while permitting direct imaging of two cardinal features of early-stage axonopathy: axonal structural integrity and axonal transport capacity. Using this system, we found via pharmacological inhibition and genetic deletion of APP that production of Aβ is a necessary step in structural compromise of retinal ganglion cell (RGC) axons induced by the disease-relevant stressor hypoxia. However, identical blockade of Aβ production was not sufficient to protect axons from associated hypoxia-induced reduction in axonal transport. Thus, Aβ mediates distinct facets of hypoxia-induced axonopathy and may represent a functionally selective pharmacological target for therapies directed against early-stage axonopathy in CNS diseases.

References

Mar 1, 1997·Brain : a Journal of Neurology·B FergusonV H Perry
Nov 5, 1997·Trends in Neurosciences·B H GähwilerS M Thompson
Apr 20, 1999·Acta Neuropathologica·P P Liberski, H Budka
May 4, 2002·Science·Martin C RaffJohn T Finn
Dec 11, 2002·Journal of Neurochemistry·Nicola J WebsterPeter F T Vaughan
Feb 5, 2003·Brain : a Journal of Neurology·I M Medana, M M Esiri
Jun 25, 2003·Experimental Neurology·Karin BorgesRaymond Dingledine
Feb 1, 2005·Annals of the New York Academy of Sciences·Natalia N NalivaevaaAnthony J Turner
Feb 26, 2005·Science·Gorazd B StokinLawrence S B Goldstein
Mar 5, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Orly LazarovSangram S Sisodia
Mar 23, 2005·The Journal of Biological Chemistry·Chuan ShenJo Anne Powell-Coffman
Oct 15, 2005·Nature Reviews. Neuroscience·Michael Coleman
Nov 18, 2005·Journal of Neuroimmunology·Maciej JurynczykKrzysztof Selmaj
Jun 20, 2006·Journal of Neuropathology and Experimental Neurology·Ilene D Auerbach, Harry V Vinters
Aug 25, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Thomas W GouldRonald W Oppenheim
Nov 14, 2006·Nature Neuroscience·Xiangyou HuRiqiang Yan
Aug 9, 2007·Proceedings of the National Academy of Sciences of the United States of America·Li GuoM Francesca Cordeiro
Dec 2, 2008·Nature Reviews. Drug Discovery·Inki KimJohn C Reed
Mar 21, 2009·Annual Review of Biochemistry·Evan T PowersWilliam E Balch
Oct 16, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Gerardo A MorfiniScott T Brady
Oct 23, 2009·Annals of the New York Academy of Sciences·Chris PeersJohn P Boyle
Feb 26, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Christopher PatzkeFritz G Rathjen
Aug 28, 2010·Current Eye Research·Anna Kipfer-KauerDavid Goldblum
Oct 15, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Bhupinder P S VohraJeffrey Milbrandt
Apr 15, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mohamed H FarahJohn W Griffin
Jun 7, 2011·Biochemical and Biophysical Research Communications·Juan LiZhiqun Tan
Sep 1, 2011·Journal of Neuroinflammation·Shlomo Rotshenker
Dec 14, 2011·Progress in Retinal and Eye Research·Mohammadali AlmasiehAdriana Di Polo
Jul 24, 2012·Trends in Biochemical Sciences·Mei Yee Koh, Garth Powis
Sep 22, 2012·High Altitude Medicine & Biology·Christian Grimm, Gabriel Willmann

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.